<?xml version="1.0" encoding="utf-8"?>
<XML>
<JOURNAL>
<YEAR>2010</YEAR>
<VOL>2</VOL>
<NO>3</NO>
<MOSALSAL>0</MOSALSAL>
<PAGE_NO>127</PAGE_NO>


<ARTICLES>

	<ARTICLE> 
		<TitleF>Myelofibrosis due to Secondary Hyperparathyroidism in a Case of Celiac Disease</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Myelofibrosis is reported in patents with primary hyperparathyroidism. It is also was reported in patents with sec-
ondary hyperparathyroidism due to end-stage renal disease or Vitamin D dependent rickets .We present a case of
celiac disease and osteomalacia which leads to secondary hyperparathyroidism and myelofibrosis.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>0</FPAGE>
			<TPAGE>0</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2011/05/18
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1390/2/28
		</RECEIVE_DATE_FA>

		<AUTHORS>		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Celiac disease, Hyperparathyroidism, Myelofibrosis</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Congenital Leukemia: A Case Report</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>0</FPAGE>
			<TPAGE>0</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2011/05/182011/05/18
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1390/2/28
		</RECEIVE_DATE_FA>

		<AUTHORS>		</AUTHORS>


		<KEYWORDS>		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Restless Legs Syndrome Prevalence in Major Thalasemia Tabriz Children Hospital</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>0</FPAGE>
			<TPAGE>0</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2011/05/182011/05/182011/05/18
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1390/2/28
		</RECEIVE_DATE_FA>

		<AUTHORS>		</AUTHORS>


		<KEYWORDS>		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Applying Totally Implantable Venous Access Devices (TIVAD) in Children: the First Iranian Experience</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>0</FPAGE>
			<TPAGE>0</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2011/05/182011/05/182011/05/182011/05/18
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1390/2/28
		</RECEIVE_DATE_FA>

		<AUTHORS>		</AUTHORS>


		<KEYWORDS>		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Density of Platelet GPIIb-IIIa and Bleeding Severity in Iranian Patients with Glanzmann’s Thrombasthenia</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>0</FPAGE>
			<TPAGE>0</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2011/05/182011/05/182011/05/182011/05/182011/05/18
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1390/2/28
		</RECEIVE_DATE_FA>

		<AUTHORS>		</AUTHORS>


		<KEYWORDS>		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Pediatric Non Hodgkin’s Lymphomas</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>0</FPAGE>
			<TPAGE>0</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2011/05/182011/05/182011/05/182011/05/182011/05/182011/05/18
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1390/2/28
		</RECEIVE_DATE_FA>

		<AUTHORS>		</AUTHORS>


		<KEYWORDS>		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Patterns of Gelatinase-B Expression in Leukemic Cell Lines</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>0</FPAGE>
			<TPAGE>0</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2011/05/182011/05/182011/05/182011/05/182011/05/182011/05/182011/05/18
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1390/2/28
		</RECEIVE_DATE_FA>

		<AUTHORS>		</AUTHORS>


		<KEYWORDS>		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Future</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>0</FPAGE>
			<TPAGE>0</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2011/05/182011/05/182011/05/182011/05/182011/05/182011/05/182011/05/182011/05/18
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1390/2/28
		</RECEIVE_DATE_FA>

		<AUTHORS>		</AUTHORS>


		<KEYWORDS>		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Intra articular Injection of Rifampin in Iranian Children with Haemophilic Arthropathy</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background:Chronic synovitis is one of the most important complications in haemophilic patients. Rifampin is anantibiotic which its intra-articular injecion leads to destruction of the synovial membrane of haemophilic patientsmedically.Materials and Methods: Between September 2003 and November 2005, we administered intra-articular rifampinin ١۶ haemophilic joints of ٨ haemophilic patients.Results:Median age of our patients was 14.5 year-old. There were 11 knee joints and 5 elbow joints. Atier treatmentwe observed significant improvement in treated joints.Conclusion:This study reveals that intra-articular injection of rifampin may improve arthropathy in haemophilicpatients.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>123</FPAGE>
			<TPAGE>127</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2011/05/182011/05/182011/05/182011/05/182011/05/182011/05/182011/05/182011/05/182011/10/31
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1390/8/9
		</RECEIVE_DATE_FA>

		<AUTHORS>		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Hemophilia, Synovitis, Rifampin.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>

</ARTICLES>

</JOURNAL>
</XML>
